MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Masimo Corporation EPS Ratio 2011-2026 | MASI
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Masimo Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.72 | 1.54 | 2.68 | 4.39 | - | 3.67 | 3.7 | 2.42 | 6.28 | 1.33 | - | 1.03 | 1.08 | 1.07 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.28 | -5.72 | 1.96 |
Quarterly EPS Ratio Masimo Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.86 | 0.95 | -3.17 | - | 0.19 | 0.3 | 0.36 | - | 0.3 | 0.4 | 1.23 | - | 0.34 | 0.84 | 1.28 | 1.05 | 0.91 | 0.97 | - | 0.9 | 1.02 | 1.2 | 0.99 | 0.92 | 0.84 | 0.93 | 0.88 | 1.09 | 0.84 | 0.88 | -0.15 | 0.69 | 0.87 | 1.02 | 4.31 | 0.56 | 0.61 | 0.56 | 0.4 | 0.38 | 0.38 | 0.39 | - | 0.28 | 0.25 | 0.4 | 0.16 | 0.28 | 0.3 | 0.29 | 0.26 | 0.24 | 0.31 | 0.27 | 0.23 | 0.25 | 0.28 | 0.3 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.31 | -3.17 | 0.542 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical instruments industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
11 | - | - | $ 810 M |  USA |
 |
Becton, Dickinson and Company
BDX
|
5.83 | $ 154.51 | -1.17 % | $ 44.4 B | USA |
 |
Repligen Corporation
RGEN
|
0.64 | $ 117.78 | -0.46 % | $ 6.56 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
-4.91 | $ 9.4 | -11.74 % | $ 22.8 M | USA |
 |
Haemonetics Corporation
HAE
|
3.33 | $ 56.83 | 1.05 % | $ 2.86 B | USA |
 |
ICU Medical
ICUI
|
0.03 | $ 123.31 | -1.53 % | $ 3.04 B | USA |
 |
Intuitive Surgical
ISRG
|
8 | $ 452.07 | -2.67 % | $ 161 B | USA |
 |
Harvard Bioscience
HBIO
|
-1.28 | $ 5.2 | 2.16 % | $ 231 M | USA |
 |
Isoray
ISR
|
-1.4 | - | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
-0.83 | $ 10.31 | -13.65 % | $ 421 M | USA |
 |
Repro Med Systems
KRMD
|
-0.06 | $ 4.32 | 1.17 % | $ 200 M | USA |
 |
AtriCure
ATRC
|
-0.24 | $ 29.07 | 2.68 % | $ 1.39 B | USA |
 |
Pulse Biosciences
PLSE
|
-1.08 | $ 23.0 | -0.13 % | $ 1.55 B | USA |
 |
InfuSystem Holdings
INFU
|
0.07 | $ 9.29 | -0.11 % | $ 192 M | USA |
 |
iRhythm Technologies
IRTC
|
-1.39 | $ 116.8 | -1.2 % | $ 3.74 B | USA |
 |
Merit Medical Systems
MMSI
|
2.17 | $ 67.7 | -0.78 % | $ 4 B | USA |
 |
BioLife Solutions
BLFS
|
-0.44 | $ 19.51 | 1.14 % | $ 899 M | USA |
 |
electroCore
ECOR
|
-1.65 | $ 6.8 | 3.03 % | $ 57.7 K | USA |
 |
STERIS plc
STE
|
6.24 | $ 218.71 | -0.56 % | $ 21.6 B | USA |
 |
Teleflex Incorporated
TFX
|
-16.1 | $ 117.81 | -0.52 % | $ 5.26 B | USA |
 |
Utah Medical Products
UTMD
|
3.48 | $ 63.12 | 0.4 % | $ 205 M | USA |
 |
OraSure Technologies
OSUR
|
-0.94 | $ 3.08 | 0.98 % | $ 226 M | USA |
 |
West Pharmaceutical Services
WST
|
6.83 | $ 254.8 | 0.82 % | $ 18.4 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-3 | $ 11.63 | -0.26 % | $ 2.32 B | USA |
 |
Glaukos Corporation
GKOS
|
-2.78 | $ 112.77 | 0.12 % | $ 5.46 B | USA |
 |
ResMed
RMD
|
5.34 | $ 224.09 | 0.56 % | $ 32.7 B | USA |
 |
Predictive Oncology
POAI
|
-13.4 | - | - | $ 31.1 M | USA |
 |
Baxter International
BAX
|
-1.87 | $ 16.68 | -0.6 % | $ 8.56 B | USA |
 |
NeuroMetrix
NURO
|
-3.96 | - | 5.05 % | $ 9.02 M | USA |
 |
STAAR Surgical Company
STAA
|
-1.62 | $ 20.21 | 4.55 % | $ 1 B | USA |
 |
Stereotaxis
STXS
|
-0.25 | $ 1.87 | 1.08 % | $ 170 M | USA |
 |
The Cooper Companies
COO
|
1.88 | $ 70.17 | -1.76 % | $ 14 B | USA |
 |
LeMaitre Vascular
LMAT
|
2.55 | $ 108.49 | -0.24 % | $ 2.46 B | USA |
 |
Microbot Medical
MBOT
|
-0.29 | $ 2.4 | 1.27 % | $ 110 M |  Israel |
 |
Nephros
NEPH
|
-0.15 | $ 2.87 | -2.21 % | $ 29.8 M | USA |
 |
Envista Holdings Corporation
NVST
|
0.28 | $ 25.81 | -0.35 % | $ 4.34 B | USA |
 |
Milestone Scientific
MLSS
|
-0.07 | $ 0.28 | -4.86 % | $ 23 M | USA |
 |
Alcon
ALC
|
0.77 | $ 74.56 | -1.26 % | $ 40.4 B |  Schweiz |
 |
Pro-Dex
PDEX
|
2.73 | $ 51.67 | 1.33 % | $ 170 M | USA |
 |
Retractable Technologies
RVP
|
-0.43 | $ 0.69 | 2.99 % | $ 20.7 M | USA |